newsfilter
← Latest News
GlobeNewswire·

Reviva to Participate in the 4th Annual Roth Healthcare Opportunities Conference

  • Reviva Pharmaceuticals Holdings, Inc. announced that Founder, President, & CEO Laxminarayan Bhat, Ph.D. will participate in a panel discussion & host one-on-one investor meetings.
  • The event is the 4th Annual Roth Healthcare Opportunities Conference, scheduled for Thursday, October 9, 2025, in New York, NY.
  • The panel titled "Small Firms Tackling Blockbuster Indications" begins at 8:00 AM ET.
  • Reviva's management team will be available for individual investor meetings on October 9, 2025.
  • The company is a late-stage biopharmaceutical developer focusing on central nervous system, inflammatory, & cardiometabolic diseases.
  • Reviva's pipeline includes two in-house discovered new chemical entities: brilaroxazine (RP5063) & RP1208.
  • Composition of matter patents for both candidates have been granted in the United States, Europe, & several other countries.